Ardelyx Inc (ARDX)
5.805
-0.08
(-1.44%)
USD |
NASDAQ |
Nov 05, 11:35
Ardelyx Price to Book Value: 8.686 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 8.813 |
| November 01, 2024 | 9.112 |
| October 31, 2024 | 8.783 |
| October 30, 2024 | 8.813 |
| October 29, 2024 | 8.993 |
| October 28, 2024 | 8.828 |
| October 25, 2024 | 8.634 |
| October 24, 2024 | 8.770 |
| October 23, 2024 | 8.350 |
| October 22, 2024 | 8.650 |
| October 21, 2024 | 8.799 |
| October 18, 2024 | 8.740 |
| October 17, 2024 | 8.725 |
| October 16, 2024 | 8.754 |
| October 15, 2024 | 8.934 |
| October 14, 2024 | 8.964 |
| October 11, 2024 | 9.039 |
| October 10, 2024 | 9.039 |
| October 09, 2024 | 8.784 |
| October 08, 2024 | 8.919 |
| October 07, 2024 | 9.174 |
| October 04, 2024 | 10.21 |
| October 03, 2024 | 9.967 |
| October 02, 2024 | 10.37 |
| October 01, 2024 | 10.25 |
| Date | Value |
|---|---|
| September 30, 2024 | 10.31 |
| September 27, 2024 | 10.65 |
| September 26, 2024 | 10.19 |
| September 25, 2024 | 9.722 |
| September 24, 2024 | 9.498 |
| September 23, 2024 | 9.482 |
| September 20, 2024 | 9.818 |
| September 19, 2024 | 9.594 |
| September 18, 2024 | 9.450 |
| September 17, 2024 | 9.850 |
| September 16, 2024 | 9.962 |
| September 13, 2024 | 10.11 |
| September 12, 2024 | 9.962 |
| September 11, 2024 | 9.546 |
| September 10, 2024 | 9.114 |
| September 09, 2024 | 9.114 |
| September 06, 2024 | 8.969 |
| September 05, 2024 | 9.242 |
| September 04, 2024 | 9.081 |
| September 03, 2024 | 9.017 |
| August 30, 2024 | 9.898 |
| August 29, 2024 | 9.818 |
| August 28, 2024 | 9.850 |
| August 27, 2024 | 9.962 |
| August 26, 2024 | 10.11 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.027
Minimum
Feb 23 2022
14.98
Maximum
Dec 19 2019
5.418
Average
4.890
Median
Mar 26 2021
Price to Book Value Benchmarks
| Verve Therapeutics Inc | 1.032 |
| United Therapeutics Corp | 2.782 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.086 |
Price to Book Value Related Metrics
| PS Ratio | 5.393 |
| PEG Ratio | -0.1149 |
| Price | 5.805 |
| Earnings Yield | -5.40% |
| Market Cap | 1.375B |
| PEGY Ratio | -0.1149 |